RAS INHIBITORS FOR TREATING DISEASES OR PATHOLOGICAL CONDITIONS CHARACTERIZED INSULIN RESISTANCE

摘要

Disclosed herein are compositions, kits and methods for treating a disease or pathological condition that is characterized, caused or mediated by insulin resistance, including, for example, Type 2 diabetes, and which employ, as an active ingredient, S-farnesylthiosalicylic acid (FTS) or a structural analog thereof, collectively defined in accordance with Formula (I).